Solubility-Directed Development of Trileucine Process
The excipient Trileucine is applied for improving aerosol performance and stability of spray-dried powders for inhalation.
At Bachem an LPPS manufacturing process for Trileucine has already been established yielding high quality material. To allow the application of Trileucine also for aqueous solutions at neutral pH, further development work was performed to enhance the water solubility of the isolated peptide.
This was successfully achieved by spray drying, but in a more straightforward way the Trileucine form with higher solubility in water could also be directly obtained by an improved crystallization process based on the results of a polymorph screening study.
To learn more about this development approach as well as about Trileucine properties, manufacturing, and application in general, watch the replay of our webinar on the solubility-directed development of the Trileucine manufacturing process.
------------------------------------------------------------------------------------------------
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
Learn more about our products and services at https://www.bachem.com/
Bachem. Leading Partner in Tides